PedAM
Pediatric Disease Annotations & Medicines
| Disease | sleep apnea |
| Phenotype | C0007222|cardiovascular disease |
| Sentences | 34 |
| PubMedID- 24714832 | Serum nitric oxide levels in the control subjects were higher than in the obstructive sleep apnea patients with and without cardiovascular diseases (p<0.05). |
| PubMedID- 22475994 | Given the elevated rates of cardiovascular diseases among individuals with sleep apnea-plus, along with their known poor cpap compliance, identification of individuals with sleep apnea-plus and treatment of their concomitant insomnia is important. |
| PubMedID- 21744318 | The rheological properties of blood and the risk of cardiovascular disease in patients with obstructive sleep apnea syndrome (osas). |
| PubMedID- 25653631 | Poor sleep quality is an independent contributor to poor health outcomes including impairments in cognition (aricò et al., 2010), white matter (kumar et al., 2014), and cardiovascular disease factors independent of sleep apnea (tosur et al., 2014). |
| PubMedID- 25808226 | Background: visceral obesity, low adiponectin, and severe obstructive sleep apnea (osa) are associated with cardiovascular diseases, but the interactions among these factors on endothelial dysfunction are not well known. |
| PubMedID- 24414066 | sleep apnea is associated with cardiovascular disease, and patients with sleep apnea have elevated plasma endothelin (et)-1 concentrations. |
| PubMedID- 20581089 | Chronic intermittent hypoxia (cih) is thought to be responsible for the cardiovascular disease associated with obstructive sleep apnea (osa). |
| PubMedID- 21993356 | Role of obstructive sleep apnea in cardiovascular disease. |
| PubMedID- 24925822 | Purpose: previous studies in the western world have reported the possible association of obstructive sleep apnea (osa) with anxiety and cardiovascular diseases. |
| PubMedID- 25169419 | Background: the prognostic significance of age and continuous positive airway pressure (cpap) therapy on cardiovascular disease in patients with sleep apnoea has not been assessed previously. |
| PubMedID- 23633759 | Study objectives: sleep disordered breathing is associated with cardiovascular disease. |
| PubMedID- 26222817 | Objective: obstructive sleep apnea syndrome is associated with cardiovascular diseases and thromboembolic events. |
| PubMedID- 22518133 | Sleep disordered breathing (sdb) and sleep apnea are associated with cardiovascular disease [1] and mortality [2]. |
| PubMedID- 23662699 | Chronic intermittent hypoxia (cih) contributes to the development of cardiovascular diseases in patients with obstructive sleep apnoea. |
| PubMedID- 25207060 | We aimed to investigate the matrix metalloproteinase-9 (mmp-9) level and mmp-9 gene polymorphism in sleep apnea patients with or without cardiovascular disease. |
| PubMedID- 25902826 | Objective: sleep disordered breathing (sdb) is associated with cardiovascular disease such as hypertension and left ventricular hypertrophy in middle-aged patients; however, this association is not well described in the elderly. |
| PubMedID- 24833762 | Obstructive sleep apnoea (osa) is associated with cardiovascular disease. |
| PubMedID- 26213710 | Edentulism was associated with cardiovascular disease independent of sleep disordered breathing. |
| PubMedID- 23618612 | Obstructive sleep apnea is common in patients with cardiovascular disease. |
| PubMedID- 24884738 | sleep apnea is associated with cardiovascular disease in the general population [34] and may be an important mediator of increased cardiovascular disease seen in hiv [35]. |
| PubMedID- 26108210 | Obstructive sleep apnea is often associated with cardiovascular diseases including coronary artery diseases and congestive heart failure [2, 3]. |
| PubMedID- 25042863 | Background: elevated levels of intercellular adhesion molecule 1 (icam-1) and vascular cell adhesion molecule 1 (vcam-1) may contribute to cardiovascular disease and are associated with obstructive sleep apnea (osa) and obesity. |
| PubMedID- 20602560 | This article examines evidence supporting associations of sleep apnea with cardiovascular disease and considers evidence suggesting cardiovascular risk reductions through sleep apnea treatment. |
| PubMedID- 22250162 | Summaries for patients: risk for death from cardiovascular disease in women with obstructive sleep apnea. |
| PubMedID- 25395095 | Salivary biomarkers indicate obstructive sleep apnea patients with cardiovascular diseases. |
| PubMedID- 23035599 | [obstructive sleep apnea: connection with cardiovascular diseases and basic methods of diagnostics]. |
| PubMedID- 22319509 | Schematic diagram underlying the sympathetic nerve system activation associated with obstructive sleep apnea syndrome that may lead to increased cardiovascular disease risk. |
| PubMedID- 24561163 | Background: sleep apnea (sa) is associated with cardiovascular diseases and is highly prevalent in patients with pacemakers (pms). |
| PubMedID- 21544202 | Recently, there has been a growing interest on sleep given the fact that numerous sleep disorders, such as insomnia and sleep disordered breathing, are strongly associated with cardiovascular diseases [25]–[27]. |
| PubMedID- 22918526 | Obstructive sleep apnoea (osa) is associated with increased cardiovascular disease (cvd) risk. |
| PubMedID- 22328886 | Obstructive sleep apnoea syndrome has been associated with hypertension and cardiovascular disease [4] and a number of studies have shown that this cardiovascular risk decreases after continuous positive airway pressure (cpap) treatment [5, 6]. |
| PubMedID- 21380796 | Background: cardiovascular diseases are frequent in patients with obstructive sleep apnea (osas). |
| PubMedID- 24701348 | The correlation between some cardiovascular diseases with sleep apnea is investigated. |
| PubMedID- 26161641 | In network 1 (fig 9, upper network), we found a link to both alb and ahsg (alpha-2-hs-glycoprotein), which is quite interesting because this protein has been recently linked to obstructive sleep apnea patients with cardiovascular diseases as a salivary biomarker [46]. |
Page: 1